Prolactinoma Clinical Trial
Official title:
PRolaCT - Three Multicenter Prolactinoma Randomized Clinical Trials
This study aims to investigate if endoscopic trans-sphenoidal prolactinoma resection as a first line treatment, or as an equally valid second line treatment after a short (4-6 months) or long (>2 years) period of pretreatment with a dopamine agonist is superior to standard care for several outcome parameters. The main objectives are to investigate this for quality of life and remission rate. The secondary objectives are to investigate this for biochemical disease control, recurrence rates, clinical symptom control, tumor shrinkage on MRI, pituitary functioning, the occurrence of adverse reactions to treatment, disease burden, and cost-effectiveness.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03038308 -
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03400865 -
Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
|
N/A | |
Completed |
NCT00481299 -
Insulin Resistance in Women With Prolactinoma
|
N/A | |
Terminated |
NCT04106531 -
Validation of a Quality of Life Metric "Prolac-10"
|
||
Completed |
NCT01504399 -
Rhinological Outcomes in Endonasal Pituitary Surgery
|
||
Recruiting |
NCT03474601 -
Seoul National University Pituitary Disease Cohort Study
|
||
Completed |
NCT00697814 -
Clomiphene in Males With Prolactinomas and Persistent Hypogonadism
|
Phase 2 | |
Completed |
NCT05236829 -
Exercise Capacity and Physical Activity Level in Prolactinoma Patients
|
||
Recruiting |
NCT03353025 -
Study on Therapy of Non-invasive Prolactinoma
|
N/A | |
Recruiting |
NCT03457389 -
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
|
N/A | |
Recruiting |
NCT01775332 -
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
|
N/A | |
Not yet recruiting |
NCT03717454 -
Dopamine D2 Receptors(D2R) Imaging in Prolactinomas
|
N/A | |
Recruiting |
NCT00001595 -
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
|